CreatorsPublishersAdvertisers
View more in
Cancer

Fixed-Volume Isatuximab-Based Combination Efficacy Confirmed for Treating Newly Diagnosed Multiple Myeloma

cancernetwork.com
 2021-09-09

Cover picture for the articleUpdated results confirmed the safety and efficacy of the quadruplet regimen of fixed-dose isatuximab-irfcc in combination with bortezomib, lenalidomide, and dexamethasone for newly diagnosed multiple myeloma with no immediate intent for transplant. Updated results confirmed the safety and efficacy of the quadruplet regimen of fixed-dose isatuximab-irfcc (Sarclisa) in combination with...

www.cancernetwork.com

Comments / 0

Comments / 0